Works matching IS 00912700 AND DT 2023 AND VI 63 AND IP 4


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 473, doi. 10.1002/jcph.2187
    By:
    • Niimura, Takahiro;
    • Zamami, Yoshito;
    • Miyata, Koji;
    • Mikami, Takahisa;
    • Asada, Mizuho;
    • Fukushima, Keijo;
    • Yoshino, Masaki;
    • Mitsuboshi, Satoru;
    • Okada, Naoto;
    • Hamano, Hirofumi;
    • Sakurada, Takumi;
    • Matsuoka‐Ando, Rie;
    • Aizawa, Fuka;
    • Yagi, Kenta;
    • Goda, Mitsuhiro;
    • Chuma, Masayuki;
    • Koyama, Toshihiro;
    • Izawa‐Ishizawa, Yuki;
    • Yanagawa, Hiroaki;
    • Fujino, Hiromichi
    Publication type:
    Article
    12
    13
    14

    Issue Information.

    Published in:
    Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 377, doi. 10.1002/jcph.1898
    Publication type:
    Article